Close

TearLab (TEAR) Calls Shire's FDA Approval of Xiidra an Important Milestone for DED

July 12, 2016 4:02 PM EDT Send to a Friend
TearLab Corporation (NASDAQ: TEAR) today recognized Shire plc on its recent US Food and Drug Administration (FDA) approval of Xiidra™ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login